Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum Immunoproteomics Combined With Pathological Reassessment of Surgical Specimens Identifies TCP-1ζ Autoantibody as a Potential Biomarker in Thyroid Neoplasia.
Belousov PV, Bogolyubova AV, Kim YS, Abrosimov AY, Kopylov AT, Tvardovskiy AA, Lanshchakov KV, Sazykin AY, Dvinskikh NY, Bobrovskaya YI, Selivanova LS, Shilov ES, Schwartz AM, Shebzukhov YV, Severskaia NV, Vanushko VE, Moshkovskii SA, Nedospasov SA, Kuprash DV. Belousov PV, et al. Among authors: sazykin ay. J Clin Endocrinol Metab. 2015 Sep;100(9):E1206-15. doi: 10.1210/jc.2014-4260. Epub 2015 Jul 21. J Clin Endocrinol Metab. 2015. PMID: 26196948
[Preparation of recombinant serpins B3 and B4 and investigation of their specific interactions with antibodies using hydrogel-based microarrays].
Butvilovskaya VI, Tsybulskaya MV, Tikhonov AA, Talibov VO, Belousov PV, Sazykin AY, Schwartz AM, Putlyaeva LV, Surzhikov SA, Stomakhin AA, Solopova ON, Rubina AY. Butvilovskaya VI, et al. Among authors: sazykin ay. Mol Biol (Mosk). 2015 Sep-Oct;49(5):790-9. doi: 10.7868/S0026898415050043. Mol Biol (Mosk). 2015. PMID: 26510597 Free article. Russian.
Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients.
Widenmeyer M, Griesemann H, Stevanović S, Feyerabend S, Klein R, Attig S, Hennenlotter J, Wernet D, Kuprash DV, Sazykin AY, Pascolo S, Stenzl A, Gouttefangeas C, Rammensee HG. Widenmeyer M, et al. Among authors: sazykin ay. Int J Cancer. 2012 Jul 1;131(1):140-9. doi: 10.1002/ijc.26365. Epub 2011 Sep 14. Int J Cancer. 2012. PMID: 21858810 Clinical Trial.
Alternative variants of human HYDIN are novel cancer-associated antigens recognized by adaptive immunity.
Laske K, Shebzukhov YV, Grosse-Hovest L, Kuprash DV, Khlgatian SV, Koroleva EP, Sazykin AY, Penkov DN, Belousov PV, Stevanovic S, Vass V, Walter S, Eisel D, Schmid-Horch BD, Nedospasov SA, Rammensee HG, Gouttefangeas C. Laske K, et al. Among authors: sazykin ay. Cancer Immunol Res. 2013 Sep;1(3):190-200. doi: 10.1158/2326-6066.CIR-13-0079. Epub 2013 Jul 5. Cancer Immunol Res. 2013. PMID: 24777681